Biomarkers in Pulmonary Nodule Diagnosis: Is It Time to Put Away the Biopsy Needle?

Affiliations

¹ Division of Pulmonary, Critical Care, Sleep and Occupational Medicine, Indiana University School of Medicine, Indianapolis, IN.
² Division of Pulmonary, Critical Care, Sleep and Occupational Medicine, Indiana University School of Medicine, Indianapolis, IN. Electronic address: crufatto@iu.edu.

Editorial

Nawar Al Nasrallah et al. Chest. 2018 Sep.

. 2018 Sep;154(3):467-468.

doi: 10.1016/j.chest.2018.04.032.

¹ Division of Pulmonary, Critical Care, Sleep and Occupational Medicine, Indiana University School of Medicine, Indianapolis, IN.
² Division of Pulmonary, Critical Care, Sleep and Occupational Medicine, Indiana University School of Medicine, Indianapolis, IN. Electronic address: crufatto@iu.edu.

No abstract available

Comment on

Assessment of Plasma Proteomics Biomarker's Ability to Distinguish Benign From Malignant Lung Nodules: Results of the PANOPTIC (Pulmonary Nodule Plasma Proteomic Classifier) Trial.
Silvestri GA, Tanner NT, Kearney P, Vachani A, Massion PP, Porter A, Springmeyer SC, Fang KC, Midthun D, Mazzone PJ; PANOPTIC Trial Team. Silvestri GA, et al. Chest. 2018 Sep;154(3):491-500. doi: 10.1016/j.chest.2018.02.012. Epub 2018 Mar 1. Chest. 2018. PMID: 29496499 Free PMC article.